| Reactome:R-HSA-211859 |
Biological oxidations |
| Reactome:R-MMU-1430728 |
Metabolism |
| Reactome:R-MMU-556833 |
Metabolism of lipids |
| Reactome:R-MMU-8957322 |
Metabolism of steroids |
| Reactome:R-MMU-211859 |
Biological oxidations |
| Reactome:R-RNO-196071 |
Metabolism of steroid hormones |
| Reactome:R-RNO-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-HSA-556833 |
Metabolism of lipids |
| Reactome:R-HSA-211976 |
Endogenous sterols |
| Reactome:R-MMU-196071 |
Metabolism of steroid hormones |
| Reactome:R-MMU-211976 |
Endogenous sterols |
| Reactome:R-RNO-193993 |
Mineralocorticoid biosynthesis |
| Reactome:R-RNO-211859 |
Biological oxidations |
| Reactome:R-HSA-193993 |
Mineralocorticoid biosynthesis |
| Reactome:R-HSA-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-MMU-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-RNO-1430728 |
Metabolism |
| Reactome:R-RNO-556833 |
Metabolism of lipids |
| Reactome:R-RNO-8957322 |
Metabolism of steroids |
| Reactome:R-RNO-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-HSA-1430728 |
Metabolism |
| Reactome:R-HSA-8957322 |
Metabolism of steroids |
| Reactome:R-HSA-196071 |
Metabolism of steroid hormones |
| Reactome:R-HSA-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-MMU-193993 |
Mineralocorticoid biosynthesis |
| Reactome:R-MMU-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-RNO-211976 |
Endogenous sterols |
| WikiPathways:WP5280 |
Glucocorticoid biosynthesis |
| PathBank:SMP0120690 |
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0120858 |
11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0030406 |
Androstenedione Metabolism |
| PathBank:SMP0121126 |
Aldosterone from Steroidogenesis |
| PathBank:SMP0000373 |
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0000576 |
21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000718 |
3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0120849 |
17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0120861 |
Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0120869 |
3-beta-Hydroxysteroid Dehydrogenase Deficiency |
| PathBank:SMP0000575 |
11-beta-Hydroxylase Deficiency (CYP11B1) |
| PathBank:SMP0000717 |
Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0120672 |
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0120860 |
Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0120868 |
Apparent Mineralocorticoid Excess Syndrome |
| PathBank:SMP0000130 |
Steroidogenesis |
| PathBank:SMP0000371 |
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH |
| PathBank:SMP0000577 |
Corticosterone Methyl Oxidase I Deficiency (CMO I) |
| PathBank:SMP0087364 |
Androstenedione Metabolism |
| PathBank:SMP0120671 |
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency |
| PathBank:SMP0120859 |
21-Hydroxylase Deficiency (CYP21) |
| PathBank:SMP0000372 |
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency |
| PathBank:SMP0000566 |
17-alpha-Hydroxylase Deficiency (CYP17) |
| PathBank:SMP0000578 |
Corticosterone Methyl Oxidase II Deficiency (CMO II) |
| PathBank:SMP0087331 |
Steroidogenesis |